Supercharging Immunotherapies for Cancer and Immune Disorders

The Immunotherapy Stream at PEGS BOSTON highlights the most exciting technologies, modalities, and engineering strategies driving cellular and non-cellular immunotherapies for cancer and immune disorders. Part One examines recent breakthroughs in immunotherapy efficacy and safety, across a range of modalities; Part Two focuses on supercharging CAR T therapies and other cell immunotherapies against liquid and solid tumors; with Part Three focusing on the next generation of smarter, more targeted immunotherapies for reprogramming the immune system. All tracks feature brand new data, exciting, inspiring science, and unrivaled networking opportunities with both industry and academic leaders.

Conferences Include:

May 15-16

Improving Immunotherapy Efficacy and Safety

May 16-17

Cell-Based Immunotherapies

May 18-19

Next-Generation Immunotherapies

Keynote Presentations:

Immunomodulation by Genomic “Dark Matter” and Extracellular Vesicles in Cancer
Laszlo G. Radvanyi, PhD, President & Scientific Director, Ontario Institute for Cancer Research

Towards In Vivo Engineering of the Immune System
Adrian Bot, MD, PhD, CSO, Executive Vice President, R&D, Capstan Therapeutics

In vivo Engineering Considering Probability of Technical, Regulatory, and Commercial Success
Nicholas A. Boyle, PhD, CEO, Abintus Bio

2025 PROGRAMS

View By:

• Display of Biologics
• Engineering Antibodies
• Machine Learning for Protein Engineering

• Antibodies for Cancer Therapy
• Emerging Targets for Oncology & Beyond
• Driving Clinical Success in Antibody-Drug Conjugates

• TS: Intro to Multispecific Antibodies
• Advancing Multispecific Antibodies
• Engineering Bispecific and Multifunctional Antibodies

• Advances in Immunotherapy
• Engineering Cell Therapies
• Next-Generation Immunotherapies

• Difficult-to-Express Proteins
• Optimizing Protein Expression
• Maximizing Protein Production Workflows

• ML and Digital Integration in Biotherapeutic Analytics
• Biophysical Methods
• Characterization for Novel Biotherapeutics

• TS: Intro to Immunogenicity
• Predicting Immunogenicity with AI/ML Tools
• TS: Bioassay Development and Analysis

• Biologics for Immunology Indications
• Radiopharmaceutical Therapies
• Next-Generation Immunotherapies

• ML and Digital Integration in Biotherapeutic Analytics
• Predicting Immunogenicity with AI/ML Tools
• Machine Learning for Protein Engineering